Critical Appraisal of Epidemiological Studies — MCQs

10 questions

Which of the following is a type of observational study that analyzes population-level data?

In a case-control study, which measure quantifies the strength of association between exposure and outcome?

A study is to be conducted to compare the fat content in the expressed breast milk of pre-term infants with that of term infants. Which study design is best suited?

Which among the following is the major practical problem in a cohort study?

What is a key benefit of Randomized Controlled Trials (RCTs) in clinical research?

In a cohort study conducted with 100 individuals in each group (exposed and non-exposed), out of those exposed to the risk factor, 10 are diseased, and out of those not exposed to the risk factor, only 5 are diseased. What is the relative risk?

Which one of the following is FALSE regarding confounding factor in epidemiological studies ?

What is the chance of HIV infection after needle prick injury?

Q10

Most commonly used blinding technique in epidemiological studies?

Critical Appraisal of Epidemiological Studies Indian Medical PG Practice Questions and MCQs

Question 1: Which of the following is a type of observational study that analyzes population-level data?

A. Ecological study (Correct Answer)
B. Case-control study
C. Randomized controlled trial
D. Longitudinal study

Explanation: ***Ecological study*** - This type of study examines the relationship between an exposure and an outcome at the **population level** rather than the individual level. - It often uses aggregated data, such as incidence rates of disease in different geographic areas, to identify associations. *Case-control study* - This is an **individual-level observational study** that compares individuals with a disease (cases) to individuals without the disease (controls) and looks back retrospectively at their exposures. - It is used to investigate potential risk factors for a disease but does not analyze population-level data directly. *Randomized controlled trial* - This is an **experimental study design** where participants are randomly assigned to an intervention group or a control group. - It is considered the gold standard for establishing causality but does not analyze observational population-level data. *Longitudinal study* - This is an **individual-level observational study** that follows the same group of individuals over a period of time, collecting data at multiple points. - While it observes changes over time, it typically focuses on individual-level trends and outcomes, not aggregated population data.

Question 2: Match the following columns on Epidemiology Guidelines: | A. CARE | 1. RCT | | :-- | :-- | | B. CONSORT | 2. Case report | | C. PRISMA | 3. Observational study | | D. STROBE/MOOSE | 4. Systematic Review |

A. A2-B1-C4-D3 (Correct Answer)
B. A2-B4-C1-D3
C. A4-B1-C3-D2
D. A4-B1-C2-D3

Explanation: ***A2-B1-C4-D3*** - **CARE Guidelines** provide essential reporting standards for **case reports** and case series to enhance their value and transparency. - **CONSORT (Consolidated Standards of Reporting Trials)** is specifically designed for the reporting of **Randomized Controlled Trials (RCTs)**. - **PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses)** provides a minimum set of items for reporting in **systematic reviews** and meta-analyses. - **STROBE (STrengthening the Reporting of OBservational studies in Epidemiology)** and **MOOSE (Meta-analysis Of Observational Studies in Epidemiology)** are reporting guidelines for **observational studies**, including cohort, case-control, and cross-sectional studies. *A2-B4-C1-D3* - Incorrectly pairs CONSORT with systematic reviews (should be RCTs) and PRISMA with RCTs (should be systematic reviews). - CONSORT is the gold standard for **reporting RCTs**, while PRISMA is designed for **systematic reviews and meta-analyses**. *A4-B1-C3-D2* - Incorrectly matches CARE with systematic reviews, PRISMA with observational studies, and STROBE/MOOSE with case reports. - CARE is specifically for **case reports and case series**, PRISMA for **systematic reviews**, and STROBE/MOOSE for **observational epidemiological studies**. *A4-B1-C2-D3* - Incorrectly pairs CARE with systematic reviews and PRISMA with case reports. - This reverses the actual purpose: CARE is designed for **case reports**, while PRISMA guides **systematic reviews and meta-analyses**.

Question 3: In a case-control study, which measure quantifies the strength of association between exposure and outcome?

A. Attributable risk
B. Hazard ratio (HR)
C. Odds ratio (OR) (Correct Answer)
D. Relative risk (RR)

Explanation: ***Odds ratio (OR)*** - The **odds ratio** is the measure of association typically used in **case-control studies** because it quantifies the odds of exposure among cases compared to the odds of exposure among controls. - It is an effective estimate of the **relative risk** when the outcome is rare. *Relative risk (RR)* - **Relative risk** is used in **cohort studies** and **randomized controlled trials** as it measures the incidence of the outcome in the exposed group compared to the unexposed group. - Calculation of RR requires knowledge of the **incidence** or **prevalence of the outcome** in both exposed and unexposed groups, which is typically not directly available in case-control studies. *Attributable risk* - **Attributable risk** (also known as risk difference) measures the **absolute difference in risk** between exposed and unexposed groups. - It indicates the **proportion of disease** in the exposed group that can be attributed to the exposure, and is primarily used in **cohort studies** for public health impact assessment. *Hazard ratio (HR)* - The **hazard ratio** is used in **survival analysis** to compare the hazard rates (instantaneous incidence rates) between two groups over time. - It is typically seen in **clinical trials** or **cohort studies** to assess the effect of an intervention or exposure on the time to an event, such as death or disease recurrence.

Question 4: A study is to be conducted to compare the fat content in the expressed breast milk of pre-term infants with that of term infants. Which study design is best suited?

A. Longitudinal study
B. Ambispective
C. Case control
D. Prospective cohort (Correct Answer)

Explanation: ***Prospective cohort*** - Among the given options, a **prospective cohort study** is the most appropriate design for this comparative study. - The study involves identifying two groups (mothers of pre-term vs. term infants) and **prospectively collecting breast milk samples** to measure and compare fat content between these groups. - This design allows for **standardized data collection** moving forward in time, ensuring consistent measurement protocols for both groups. - While this is essentially a comparative cross-sectional measurement, the prospective nature ensures proper sample collection and reduces recall bias. *Case control* - This design is used to compare **exposures** between those with and without an outcome (typically a disease). - Fat content in breast milk is a **continuous biological variable**, not a disease outcome, making case-control design inappropriate. - Case-control studies work backward from outcome to exposure, which doesn't fit this scenario where we're comparing groups defined by infant term status. *Longitudinal study* - While **prospective cohort** is a type of longitudinal study, this term is too broad and non-specific. - Longitudinal studies involve repeated measurements over time, but this question asks for a specific study design for comparing two groups. - Simply stating "longitudinal study" doesn't specify the comparative framework needed. *Ambispective* - An **ambispective (or ambi-directional) study** combines retrospective and prospective components, using existing historical data plus new follow-up. - This design is unnecessary here as there's no indication of existing historical data to utilize. - The study can be conducted entirely prospectively by identifying mothers and collecting fresh breast milk samples for analysis.

Question 5: Which among the following is the major practical problem in a cohort study?

A. Differential loss of follow up (Correct Answer)
B. Long duration of study
C. Can be used only for rare conditions
D. No significant problems with cohort studies.

Explanation: ***Differential loss of follow up*** - **Differential loss to follow-up** occurs when participants lost to follow-up differ systematically concerning exposure and outcome, potentially introducing **selection bias**. - This is a significant practical problem as it can distort the observed association between exposure and outcome, leading to biased results. *Long duration of study* - While **cohort studies** can indeed be **longitudinal** and require a long duration, this is more of an inherent characteristic and resource challenge rather than a "problem" that significantly compromises the validity of the study design itself. - The long duration primarily affects costs and feasibility but doesn't inherently invalidate the findings as much as differential loss to follow-up. *Can be used only for rare conditions* - This statement is incorrect; **cohort studies** are actually **inefficient for rare diseases** because a very large sample size would be needed to observe enough cases of the outcome. - **Case-control studies** are generally preferred for investigating **rare conditions** due to their retrospective outcome-to-exposure design. *No significant problems with cohort studies.* - This statement is incorrect; **cohort studies**, like all observational study designs, have inherent **methodological challenges** and potential sources of bias. - Problems include the **cost** and **time commitment**, **loss to follow-up**, and the potential for **confounding**, all of which require careful consideration in study design and analysis.

Question 6: What is a key benefit of Randomized Controlled Trials (RCTs) in clinical research?

A. They can be conducted more quickly than other study types.
B. They minimize selection bias. (Correct Answer)
C. They are ideal for studying rare diseases.
D. They are generally less expensive than other study types.

Explanation: ***They minimize selection bias.*** - **Randomization** in RCTs ensures that participants have an equal chance of being assigned to any of the treatment groups, thereby balancing potential **confounding factors** across groups. - This balance helps to ensure that any observed differences in outcomes between groups are more likely due to the intervention being studied rather than pre-existing differences among participants, thus minimizing **selection bias**. *They can be conducted more quickly than other study types.* - RCTs often require **extensive planning**, recruitment, and follow-up periods, making them one of the **most time-consuming** study designs. - The need for sufficient **power** to detect meaningful differences often translates into longer study durations. *They are ideal for studying rare diseases.* - Due to the requirement for **large sample sizes** to demonstrate statistical significance, RCTs are **not practical** for diseases with low prevalence. - Recruiting enough participants with a rare disease for an RCT can be extremely challenging and often **unfeasible**. *They are generally less expensive than other study types.* - RCTs are typically among the **most expensive** study designs because they involve extensive participant recruitment, intervention administration, data collection, and long-term follow-up. - The costs associated with staff, resources, and monitoring for ethical compliance contribute to their **high financial burden**.

Question 7: In a cohort study conducted with 100 individuals in each group (exposed and non-exposed), out of those exposed to the risk factor, 10 are diseased, and out of those not exposed to the risk factor, only 5 are diseased. What is the relative risk?

A. 2 (Correct Answer)
B. 1.5
C. 0.75
D. 1

Explanation: ***Correct Option: 2*** - The **incidence in the exposed group** is 10/100 = 0.1. - The **incidence in the non-exposed group** is 5/100 = 0.05. - **Relative risk (RR)** is calculated as the ratio of the incidence in the exposed group to the incidence in the non-exposed group: 0.1 / 0.05 = 2. - This indicates that the **exposed group has twice the risk** of developing the disease compared to the non-exposed group. *Incorrect Option: 1.5* - This value would be obtained if the ratio of incidences was 0.075 / 0.05 or 0.1/0.066, which is not consistent with the given data. - An RR of 1.5 indicates a **lesser strength of association** than what is observed in this study. *Incorrect Option: 0.75* - This value would result if the incidence in the exposed group was *lower* than in the non-exposed group (e.g., 0.05 / 0.066), suggesting a **protective effect**. - An RR < 1 implies that exposure is protective rather than a risk factor, which contradicts the given data. *Incorrect Option: 1* - A **relative risk of 1** indicates there is no difference in the risk of disease between the exposed and non-exposed groups. - This would mean the incidence rate in both groups is identical (e.g., 0.1 / 0.1 = 1), which contradicts the provided data where exposed group has higher incidence.

Question 8: Which one of the following is FALSE regarding confounding factor in epidemiological studies ?

A. Source of bias is interpretation
B. Associated both with exposure and disease
C. Independent risk factor for disease in question
D. Distributed equally between study and control groups (Correct Answer)

Explanation: ***Distributed equally between study and control groups*** - A **confounding factor** is, by definition, **not equally distributed** between study (exposed) and control (unexposed) groups, as this unequal distribution leads to the observed bias. - If a potential confounder were equally distributed, it would not distort the relationship between the exposure and the outcome. *Source of bias is interpretation* - Confounding is a source of **bias in interpretation** because it can create a spurious association or mask a true one between an exposure and an outcome. - It leads to an incorrect conclusion about the causal relationship, even if the data collection itself was accurate. *Associated both with exposure and disease* - For a variable to be a confounder, it must be **associated with the exposure** being studied (e.g., smoking is associated with alcohol consumption). - It must also be an **independent risk factor for the disease** outcome (e.g., alcohol consumption is an independent risk factor for esophageal cancer). *Independent risk factor for disease in question* - A confounder must be an **independent risk factor** for the disease outcome, separate from its association with the primary exposure. - This means it influences the disease risk regardless of the exposure being investigated.

Question 9: What is the chance of HIV infection after needle prick injury?

A. 1/300 (Correct Answer)
B. 1/100
C. 1/10000
D. 1 in 1 Lakh

Explanation: ***1/300*** - The risk of **HIV transmission** from a percutaneous exposure (e.g., needlestick) from an HIV-infected source is estimated to be approximately **0.3%**, or **1 in 300** - This is the **established standard risk** based on CDC and WHO occupational safety guidelines - Risk factors that may increase transmission include **deeper injury**, **larger blood volume**, **hollow-bore needle**, **visible blood on device**, and **high viral load** in the source patient *1/100* - This represents a **higher risk (1%)** than typically observed for occupational HIV needlestick injuries - The 1/100 risk is more commonly associated with **Hepatitis C virus (HCV)** transmission after percutaneous exposure, which has significantly higher infectivity than HIV *1/10000* - This represents a **significantly lower risk (0.01%)** than the established average for HIV transmission via needlestick injury - This underestimates the actual occupational risk and could lead to inadequate post-exposure prophylaxis measures *1 in 1 Lakh (1/100,000)* - This represents an **extremely low probability (0.001%)** of transmission, far below the known risk of HIV infection via needlestick - Such a remote risk would be more appropriate for **mucocutaneous exposures** or **intact skin contact**, not percutaneous injuries

Question 10: Most commonly used blinding technique in epidemiological studies?

A. None of the options
B. Single blinding
C. Double blinding (Correct Answer)
D. Triple blinding

Explanation: ***Double blinding*** - In **double blinding**, neither the **participants** nor the **researchers** administering the intervention and collecting data know who is in the treatment group versus the control group. - This method is widely used to prevent **observer bias** from the researchers and **participant bias** (e.g., placebo effect) from the subjects, thereby strengthening the study's internal validity. *Single blinding* - In **single blinding**, only the **participants** are unaware of their assignment to either the treatment or control group. - While it helps reduce participant bias, the **researchers' knowledge** of group assignments can still introduce **observer bias**, making it less rigorous than double blinding. *Triple blinding* - **Triple blinding** extends double blinding by ensuring that the **data analysts** are also unaware of the participant group assignments. - This technique further minimizes bias in the **interpretation and analysis of results**, but it is less commonly implemented due to its complexity and increased logistical challenges compared to double blinding. *None of the options* - This option is incorrect because **blinding techniques** are fundamental tools in epidemiological studies and clinical trials to ensure the objectivity and reliability of research findings. - **Blinding** helps eliminate conscious and unconscious biases that could otherwise influence study outcomes.

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free